絞り込み

17360

広告

「"Rutkowski P "[Author]」の検索結果

368件中 201件~220件表示    検索結果をPubMedで見る PubMedで見る

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: A European multicenter analysis based on ConticaGIST.

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas.

Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study.

The Outcome of Targeted Therapy in Advanced Gastrointestinal Stromal Tumors (Gist) with Non-Exon 11 Kit Mutations.

Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study.

Follow-up in soft tissue sarcomas.

Follow-up in melanoma patients.

Guidelines for time-to-event endpoint definitions in sarcomas and gastro-intestinal stromal tumors (GIST) trials. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation.

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.

Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.

Melanoma Early Detection and Awareness: How Countries Developing Melanoma Awareness Programs Could Benefit From Melanoma-Proficient Countries.

[Molecular-clinical issues of gastrointestinal stromal tumors].

Taxonomic position and phylogeny of the genus Vargasiella (Orchidaceae, Vandoideae) based on molecular and morphological evidence.

Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.

Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features.

Patient Perception of the Benefit of a BRAF Inhibitor in Metastatic Melanoma: Quality of Life Analyses of the BREAK-3 Study Comparing Dabrafenib With DTIC.

Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors.

Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa.

  1. 7
  2. 8
  3. 9
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
Sort by
※並べ替えは表示に時間がかかります